logo
Plus   Neg
Share
Email

Roche Q1 Sales Up 9%; Raises FY Outlook

Swiss drug major Roche (RHHBY) reported that its group sales for the first-quarter rose 9 percent to 14.83 billion Swiss francs from last year's 13.58 billion francs, while it was up 8 percent at constant exchange rates. The company raised outlook for 2019.

Sales in the Pharmaceuticals Division increased 10% to 11.9 billion francs. The growth drivers were the multiple sclerosis medicine Ocrevus and cancer medicines Perjeta and Tecentriq as well as the new haemophilia medicine Hemlibra. The strong uptake of newly introduced medicines was partially offset by lower sales of Herceptin and of MabThera/Rituxan, the company said.

In the US, sales increased 14%, led by Ocrevus, Hemlibra, Perjeta and Tecentriq. Ocrevus sales were driven by both new and continuing patient demand.

For 2019, Roche now expects sales to grow in the mid-single digit range, at constant exchange rates. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. It expects to further increase its dividend in Swiss francs.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon Inc. is leading a new $575 million investment in British food delivery company Deliveroo, intensifying the e-commerce giant's competition with rival Uber and its Uber Eats service. Deliveroo noted that Amazon is set to be the largest investor in the Series G preferred shared funding round. With the latest funding round, Deliveroo has raised $1.53 billion. While reporting financial results for the first quarter on Friday, Deere & Co. (DE) slashed its earnings and revenue growth guidance for the full-year 2019. The company said the lower forecast is partly a result of actions taken by it to prudently manage field inventories, which will cause production... European Union regulators on Thursday fined five global banks a total of 1.07 billion euros, or $1.2 billion, for participating in foreign exchange spot trading cartels and manipulating the foreign-exchange currency market. The five banks are Barclays, Royal Bank of Scotland, Citigroup, JPMorgan Chase and Japan's MUFG Bank, formerly known as Bank of Tokyo-Mitsubishi.
Follow RTT